Business Description
Epsilon Healthcare Ltd
ISIN : AU0000137598
Compare
Compare
Traded in other countries / regions
EPN.Australia9TH0.GermanyHDRPF.USA IPO Date
2017-05-04Description
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -0.87 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -4.89 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.6 | |||||
| 3-Year EBITDA Growth Rate | 24.9 | |||||
| 3-Year EPS without NRI Growth Rate | 25.1 | |||||
| 3-Year FCF Growth Rate | 46.1 | |||||
| 3-Year Book Growth Rate | -42.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | 9.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.54 | |||||
| Quick Ratio | 0.52 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 27.18 | |||||
| Days Sales Outstanding | 142.28 | |||||
| Days Payable | 242.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.2 | |||||
| Shareholder Yield % | 9.55 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.18 | |||||
| Operating Margin % | -85.75 | |||||
| Net Margin % | -82.17 | |||||
| FCF Margin % | -36.97 | |||||
| ROE % | -61.33 | |||||
| ROA % | -30.61 | |||||
| ROIC % | -33.41 | |||||
| ROC (Joel Greenblatt) % | -36.6 | |||||
| ROCE % | -43.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.14 | |||||
| PB Ratio | 0.77 | |||||
| Price-to-Tangible-Book | 0.8 | |||||
| EV-to-EBIT | -1.76 | |||||
| EV-to-EBITDA | -3.02 | |||||
| EV-to-Revenue | 1.34 | |||||
| EV-to-FCF | -3.63 | |||||
| Earnings Yield (Greenblatt) % | -56.82 | |||||
| FCF Yield % | -37 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers